Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 485272, 7 pages
http://dx.doi.org/10.1155/2013/485272
Review Article

Treatment of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines with Special Emphasis on Complementary and Alternative Therapies

1Department of Rheumatology, Tel Aviv Sourasky Medical Center, 64239 Tel Aviv, Israel
2Division of Rheumatology, Alan Edwards Pain Management Unit, McGill University Health Centre, Canada
3Department of Medicine, H. Soroka Medical Center, 84101 Beer Sheva, Israel
4Edwards Pain management Unit, McGill University Health Centre, Canada H3G 1A4
5Department of Neurology, Universitätsklinikum Würzburg, 81865 Würzburg, Germany
6Department Internal Medicine I, Klinikum Saarbrücken, 66119 Saarbrücken, Germany
7Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, München, 90780 Würzburg, Germany

Received 9 April 2013; Accepted 1 October 2013

Academic Editor: Jost Langhorst

Copyright © 2013 Jacob Ablin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. M. Bennett, J. Jones, D. C. Turk, I. J. Russell, and L. Matallana, “An internet survey of 2,596 people with fibromyalgia,” BMC Musculoskeletal Disorders, vol. 8, article 27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Häuser, E. Jung, B. Erbslöh-Möller et al., “The German fibromyalgia consumer reports—a cross-sectional survey,” BMC Musculoskeletal Disorders, vol. 13, article 74, 2012 (German). View at Publisher · View at Google Scholar
  3. U. Marschall, B. Arnold, and W. Häuser, “Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the barmer health insurance BEK from 2008-2009,” Schmerz, vol. 25, no. 4, pp. 402–404, 406–410, 2011 (German). View at Publisher · View at Google Scholar · View at Scopus
  4. J. Lachaine, C. Beauchemin, and P.-A. Landry, “Clinical and economic characteristics of patients with fibromyalgia syndrome,” Clinical Journal of Pain, vol. 26, no. 4, pp. 284–290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Häuser, K. Thieme, and D. C. Turk, “Guidelines on the management of fibromyalgia syndrome—a systematic review,” European Journal of Pain, vol. 14, no. 1, pp. 5–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. National Center for Complementary and Alternative Medicine, “What is complementary and alternative medicine?” 2013, http://nccam.nih.gov/health/whatiscam.
  7. Oxford Center of Evidence Based Medicine, “Levels of evidence (march 2009),” http://www.cebm.net/?o=1025.
  8. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), “Program for national disease management guidelines,” Report of Methods 4, 2010, http://www.versorgungsleitlinien.de/methodik/reports. View at Publisher · View at Google Scholar
  9. M. A. Fitzcharles, P. A. Ste-Marie, D. L. Goldenberg et al., “2012 Canadian guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary,” Pain Research&Management, vol. 18, no. 3, pp. 119–126, 2013. View at Google Scholar
  10. W. Eich, W. Häuser, B. Arnold et al., “Fibromyalgia syndrome. general principles and coordination of clinical care and patient education,” Schmerz, vol. 26, no. 3, pp. 268–275, 2012 (German). View at Publisher · View at Google Scholar
  11. C. Sommer, W. H. Häuser, R. Alten et al., “Drug therapy of fibromyalgia syndrome. systematic review, meta-analysis and guideline,” Schmerz, vol. 26, no. 3, pp. 297–310, 2012 (German). View at Publisher · View at Google Scholar
  12. V. Köllner, W. Häuser, K. Klimczyk et al., “Psychotherapy for patients with fibromyalgia syndrome. systematic review, meta-analysis and guideline,” Schmerz, vol. 26, no. 3, pp. 291–296, 2012 (German). View at Publisher · View at Google Scholar
  13. A. Winkelmann, W. Häuser, E. Friedel et al., “Physiotherapy and physical therapies for fibromyalgia syndrome. systematic review, meta-analysis and guideline,” Schmerz, vol. 26, no. 3, pp. 276–286, 2012 (German). View at Publisher · View at Google Scholar
  14. J. Langhorst, W. Häuser, K. Bernardy et al., “Complementary and alternative therapies for fibromyalgia syndrome. systematic review, meta-analysis and guideline,” Schmerz, vol. 26, no. 3, pp. 311–317, 2012 (German). View at Google Scholar
  15. B. Arnold, W. Häuser, M. Arnold et al., “Multicomponent therapy of fibromyalgia syndrome. systematic review, meta-analysis and guideline,” Schmerz, vol. 26, no. 3, pp. 287–290, 2012 (German). View at Publisher · View at Google Scholar
  16. J. N. Ablin, H. Amital H, M. Ahrenfeld et al., “Guidelines for the diagnosis and treatment of the fibromyalgia syndrome,” Harefuah, 2013, http://www.ima.org.il/Ima/FormStorage/Type7/clinical_68_fibrom.pdf (Hebrew).
  17. R. Schaefert, C. Hausteiner-Wiehle, W. Häuser, J. Ronel, M. Herrman, and P. Henningsen, “Non-specific, functional, and somatoform bodily complaints,” Deutsches Arzteblatt International, vol. 109, no. 47, pp. 803–813, 2012. View at Publisher · View at Google Scholar
  18. M. Pioro-Boisset, J. M. Esdaile, and M. A. Fitzcharles, “Alternative medicine use in fibromyalgia syndrome,” Arthritis Care and Research, vol. 9, no. 1, pp. 13–17, 1996. View at Google Scholar · View at Scopus